Sutro Biopharma, Inc.
STRO
Rank in Stocks
#17230
Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the... Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free protein synthesis with precise, site-specific drug conjugation. Currently, Sutro's pipeline features two lead antibody-drug conjugate (ADC) candidates, both undergoing Phase 1 clinical evaluation. STRO-001 targets the CD74 protein, designed for individuals with multiple myeloma and non-Hodgkin lymphoma. The second candidate, STRO-002, is engineered to bind to folate receptor-alpha, intended for the treatment of ovarian and endometrial cancers. Strategic alliances are also a key part of its strategy, including collaborations and licensing agreements. A partnership with Merck aims to advance research programs involving cytokine derivatives for both oncological and autoimmune applications. Additionally, an agreement with Celgene Corporation focuses on identifying and developing bispecific antibodies and/or ADCs specifically within the immuno-oncology domain. Founded in 2003, the company initially operated under the name Fundamental Applied Biology, Inc. Its corporate headquarters are located in South San Francisco, California.
Share Price
$10.61
Last synced: 2026-11-09
Market Cap
$175.93M
Change (1 day)
10.29%
Change (1 year)
14.21%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Sutro Biopharma, Inc. (STRO)
Category
Healthcare
Stock split history for Sutro Biopharma, Inc. (STRO)
Sutro Biopharma, Inc. stock (symbol: STRO) underwent a total of 1 stock splits.
The most recent stock split occurred on Dec 03, 2025.
One STRO share bought prior to Dec 03, 2025 would equal to 0.1 STRO shares today.
The most recent stock split occurred on Dec 03, 2025.
One STRO share bought prior to Dec 03, 2025 would equal to 0.1 STRO shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2025-12-03 | 1:10 | x0.1 | x0.1 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
Questions about Sutro Biopharma, Inc.'s stock splits
How many times has Sutro Biopharma, Inc. split its stock?
Sutro Biopharma, Inc. (STRO) has split its stock once, on Dec 3, 2025.
How many shares would one Sutro Biopharma, Inc. share bought before Dec 3, 2025 be today?
After all its stock splits, one share bought before Dec 3, 2025 would be 0.1 shares today.